赛托生物: 关于2025年半年度利润分配预案的公告

Group 1 - The company reported a net profit attributable to ordinary shareholders of -52,687,137.35 yuan for the first half of 2025, while the parent company achieved a net profit of 2,477,250.60 yuan [1] - As of June 30, 2025, the cumulative net profit available for distribution to investors in the consolidated financial statements was 224,112,175.52 yuan [1] - The proposed profit distribution plan is to distribute 1.18 yuan per share (including tax) to all shareholders based on the total share capital of 189,702,126 shares, with no bonus shares or capital reserve conversion [2] Group 2 - The profit distribution plan complies with relevant regulations including the Company Law and accounting standards, ensuring legality, compliance, and reasonableness [2] - The implementation of the profit distribution plan is subject to approval at the company's first extraordinary general meeting of 2025, indicating a level of uncertainty [2]